Persistent infection of human intestinal Caco-2 cell line by Coxsackieviruses B

Pathologie Biologie

Volumn 60, Issue 6, 2012, Pages 347-351

  Riabi, S ^a   Gaaloul, I ^a   Harrath, R ^a   Aouni, M ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Caco 2 cells; CV B; Enterovirus; IFI; PCR; Persistent infection; Serotype

Indexed keywords

CAPSID PROTEIN; PROTEIN VP1; VIRUS RNA;

ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE INFECTION; PERSISTENT INFECTION; PROTEIN ANALYSIS; SEROTYPE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

CACO-2 CELLS; CAPSID PROTEINS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTESTINES; RNA, VIRAL; SEROTYPING; VIRION;

EID: 84870390841     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.11.004     Document Type: Article

References (54)

1. King A.M., Brown Q.F., Christian P., et al. Picornaviridae. Seventh report of the International Committee on Taxonomy of Viruses. Virus taxonomy: classification and nomenclature of viruses 2000, 657-678. Academic Press, San Diego, California. M.H.V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E.B. Carstens, M.K. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle, R.B. Wickner (Eds.).
2. Chapman N.M., Ramsingh A.I., Tracy S. Genetics of coxsackievirus virulence. Curr Top Microbiol Immunol 1997, 223:227-258.
3. Muckelbauer J.K., Kremer M., Minor I., Diana G., Dutko F.J., Groarke J., et al. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 1995, 3:653-667.
4. Baboonian C., Davies M.J., Booth J.C., McKenna W.J. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 1997, 223:31-52.
5. Drescher K., Kono K., Bopegamage S., Carson S.D., Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004, 329:381-394.
6. Modlin J.F., Rotbart H.A., Group B coxsackie disease in children. Curr Top Microbiol Immunol 1997, 223:53-80.
7. Chapman N.M., Kim K.S. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008, 323:275-292.
8. Feuer R., Ruller C.M., An N., Tabor-Godwin J.M., Rhoades R.E., Maciejewski S., et al. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 2009, 83:9356-9369.
9. Jaïdane H., Sauter P., Sane F., Goffard A., Gharbi J., Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 2010, 20(5):265-280.
10. Diez J., Davila M., Escarmis C., Mateu M.G., Dominguez J., Perez J.J., et al. Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J Virol 1990, 64:5519-5528.
11. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection-quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 1992, 89:314-318.
12. Han J., Ma X.J., Wan J.F., Liu Y.H., Han Y.L., Chen C., et al. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect Dis 2010, 10:178.
13. Colbere-Garapin F., Duncan G., Pavio N., Pelletier I., Petit I. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin. Clin Diagn Virol 1998, 9:107-113.
14. Reagan K.J., Goldberg B., Crowell R.L. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 1984, 49:635-640.
15. Tam P.E., Messner R.P. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 1999, 73:10113-10121.
16. Bowles N.E., Bayston T.A., Zhang H.Y., Doyle D., Lane R.J., Cunningham L., et al. Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J Med 1993, 24:145-160.
17. Chia J., Chia A., Voeller M., Lee T., Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol 2010, 63:165-168.
18. Zhang H., Li Y., McClean D.R., Richardson P.J., Florio R., Sheppard M., et al. Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes. Med Microbiol Immunol 2004, 193:109-114.
19. Woodall C.J., Riding M.H., Graham D.I., Clements G.B. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. Br Med J 1994, 308:1541-1543.
20. Arbustini E., Grasso M., Porcu E., Bellini O., Diegoli M., Fasani R., et al. and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1997, 80:1188-1193.
21. Archard L.C., Bowles N.E., Cunningham L., Freeke C.A., Olsen E.G., Rose M.L., et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 1991, 12(Suppl. D):56-59.
22. Bowles N.E., Richardson P.J., Olsen E.G., Archard L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1120-1123.
23. Leparc-Goffart I., Julien J., Fuchs F., Janatova I., Aymard M., Kopecka H. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J. Clin. Microbiol 1996, 34:2023-2026.
24. Fohlman J., Friman G., Tuvemo T. Enterovirus infections in new disguise. Lakartidningen 1997, 94:2555-2560.
25. Reetoo K.N., Osman S.A., Illavia S.J., Cameron-Wilson C.L., Banatvala J.E., Muir P. Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 2000, 81:2755-2762.
26. Li Y., Peng T., Yang Y., Niu C., Archard L.C., Zhang H. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 2000, 83:696-701.
27. Archard L.C., Khan M.A., Soteriou B.A., Zhang H., Why H.J., Robinson N.M., et al. Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 1998, 29(6):578-584.
28. Whitton J.L., Immunopathology during coxsackievirus infection. Springer Semin Immunopathol 2002, 24(2):201-203.
29. Reed L.J., Muench M. A simple method for estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
30. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
31. Zoll G.J., Melchers W.J., Kopecka H., Jambroes G., van der Poel H.J., Galama J.M. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J Clin Microbiol 1992, 30(1):160-165.
32. Oberste M.S., Nix W.A., Maher K., Pallansch M.A. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol 2003, 26(3):375-377.
33. Nasri D., Bouslama L., Omar S., Saoudin H., Bourlet T., Aouni M., et al. Typing of human enterovirus by partial sequencing of VP2. J Clin Microbiol 2007, 45(8):2370-2379.
34. Henke A., Huber S.A., Stelzner A., Whitton J.L. The role of CD8_T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995, 69:6720-6728.
35. Whitton J.L., Feuer R. Myocarditis, microbes, and autoimmunity. Autoimmunity 2004, 37:375-386.
36. Hober D., Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010, 6(5):279-289.
37. Tam P.E., Fontana D.R., Messner R.P. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses. J Lab Clin Med 2003, 142:196-204.
38. Conaldi P.G., Biancone L., Bottelli A., De Martino A., Camussi G., Toniolo A. Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol 1997, 71:9180-9187.
39. Heim A., Canu A., Kirschner P., Simon T., Mall G., Hofschneider P.H., et al. Synergistic interaction of interferon-b and interferon-g in coxsackievirus B3 infected carrier cultures of human myocardial fibroblasts. J Infect Dis 1992, 166:958-965.
40. Matteucci D., Toniolo A., Conaldi P.G., Basolo F., Gori Z., Bendinelli M. Systemic lymphoid atrophy in coxsackie B3 infected mice: effects of virus and immunopotentiating agents. J Infect Dis 1985, 151:1100-1108.
41. Brilot F., Chehadeh W., Charlet-Renard C., Martens H., Geenen V., Hober D. Persistent infection of human thymic epithelial cells by Coxsackievirus B4. J Virol 2002, 76(10):5260-5265.
42. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattré P., et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000, 74(21):10153-10164.
43. Harrath R., Bourlet T., Delézay O., Douche-Aourik F., Omar S., Aouni M., et al. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. J Med Virol 2004, 74(2):283-290.
44. Calvez V., Pelletier I., Couderc T., Pavio-Guedo N., Blondel B., Colbère-Garapin F. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Virology 1995, 212:309-322.
45. Labadie K., Pelletier I., Saulnier A., Martin J., Colbère-Garapina F. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells. Virology 2004, 318:66-78.
46. Colbère-Garapin F., Pelletier I., Ouzilou L. Persistent infections by picornaviruses. Molecular biology of Picornaviruses 2002, 437-450. ASM Press, Washington. B.L.S.E. Wimmer (Ed.).
47. Salt J.S. Persistent infection with foot-and-mouth disease virus. Top Trop Virol 1998, 1:77-129.
48. Rodriguez M., Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 1987, 7:325-365.
49. Colbere-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A 1989, 86:7590-7594.
50. Labadie K., Saulnier A., Martin-Latil S., Colbère-Garapin F. Reduced apoptosis in human intestinal cells cured of persistent Poliovirus infection. J Virol 2007, 81(6):3033-3036.
51. Oldstone M.B. Viral persistence: parameters, mechanisms and future predictions. Virology 2006, 5(344(1)):111-118.
52. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., et al. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 1992, 186(2):398-408.
53. Wimmer E., Nomoto A. Molecular biology and cell-free synthesis of poliovirus. Biologicals 1993, 21(4):349-356.
54. Pelletier I., Duncan G., Colbere-Garapin F. One amino acid change on the capsid surface of poliovirus Sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Virology 1998, 241:1-13.